CVAC
Price
$5.38
Change
-$0.02 (-0.37%)
Updated
Jun 27 closing price
Capitalization
1.21B
46 days until earnings call
MRNA
Price
$27.16
Change
-$0.38 (-1.38%)
Updated
Jun 27 closing price
Capitalization
10.5B
31 days until earnings call
Interact to see
Advertisement

CVAC vs MRNA

Header iconCVAC vs MRNA Comparison
Open Charts CVAC vs MRNABanner chart's image
CureVac
Price$5.38
Change-$0.02 (-0.37%)
Volume$770.68K
Capitalization1.21B
Moderna
Price$27.16
Change-$0.38 (-1.38%)
Volume$11.55M
Capitalization10.5B
CVAC vs MRNA Comparison Chart in %
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. MRNA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Buy and MRNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CVAC: $5.40 vs. MRNA: $27.16)
Brand notoriety: CVAC: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 0% vs. MRNA: 103%
Market capitalization -- CVAC: $1.21B vs. MRNA: $10.5B
CVAC [@Biotechnology] is valued at $1.21B. MRNA’s [@Biotechnology] market capitalization is $10.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 1 TA indicator(s) are bullish while MRNA’s TA Score has 5 bullish TA indicator(s).

  • CVAC’s TA Score: 1 bullish, 6 bearish.
  • MRNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а -0.74% price change this week, while MRNA (@Biotechnology) price change was +4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CVAC is expected to report earnings on Aug 14, 2025.

MRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($10.5B) has a higher market cap than CVAC($1.21B). CVAC YTD gains are higher at: 57.771 vs. MRNA (-34.680). CVAC has higher annual earnings (EBITDA): 228M vs. MRNA (-3.2B). MRNA has more cash in the bank: 5.98B vs. CVAC (442M). CVAC has less debt than MRNA: CVAC (37.4M) vs MRNA (745M). MRNA has higher revenues than CVAC: MRNA (3.14B) vs CVAC (524M).
CVACMRNACVAC / MRNA
Capitalization1.21B10.5B12%
EBITDA228M-3.2B-7%
Gain YTD57.771-34.680-167%
P/E Ratio5.77N/A-
Revenue524M3.14B17%
Total Cash442M5.98B7%
Total Debt37.4M745M5%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACMRNA
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNAV27.090.32
+1.19%
Mohr Company Nav ETF
BSVO20.470.12
+0.59%
EA Bridgeway Omni Small-Cap Value ETF
CPII19.18N/A
N/A
American Beacon Ionic Inflation Prot ETF
BJAN49.88-0.02
-0.03%
Innovator US Equity Buff ETF™ Jan
PNI6.65-0.04
-0.54%
PIMCO NEW YORK Municipal Income FUND II

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with AIM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-0.37%
AIM - CVAC
43%
Loosely correlated
-7.04%
MRNA - CVAC
41%
Loosely correlated
-1.38%
BNTX - CVAC
41%
Loosely correlated
+0.55%
IMNM - CVAC
38%
Loosely correlated
-0.23%
ARCT - CVAC
37%
Loosely correlated
-7.49%
More

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
-1.38%
ARCT - MRNA
50%
Loosely correlated
-7.49%
BNTX - MRNA
50%
Loosely correlated
+0.55%
CRSP - MRNA
46%
Loosely correlated
N/A
NVAX - MRNA
45%
Loosely correlated
-1.92%
RGNX - MRNA
45%
Loosely correlated
-4.11%
More